Cancer Research Excellence Award
Moumita Hazra — Hi-Tech Medical College and Hospital · India
Moumita Hazra is researcher and her profile identifies in the context of pharmacology and medically relevant clinical research. The Research record lists publications addressing pharmacovigilance, rational pharmacotherapy, medication safety and clinical treatment comparisons. [1]
Abstract
This profile summarizes the scholarly record of Moumita Hazra, whose listed work covers clinical pharmacology, pharmacoepidemiology and pharmacovigilance. The record includes studies of haematinics, topical acne therapies, asthma medication and metformin. These subjects relate to treatment effectiveness and medication safety, although the available evidence does not independently establish a cancer-specific research portfolio or award outcome. [1]
Keywords
Moumita Hazra, Cancer Research Excellence Award, pharmacology, clinical pharmacology, pharmacovigilance, rational pharmacotherapy, pharmacoepidemiology, medication safety and clinical research.
Introduction
Clinical pharmacology evaluates the use, safety and effects of medicines in patients. Pharmacovigilance and pharmacoepidemiology contribute to monitoring adverse effects and examining treatment patterns. Hazra’s listed publications include work in these areas, offering a relevant foundation for a profile centred on medicine-related research. [1]
Research Profile
The Google Scholar document identifies pharmacology and clinical pharmacology among Hazra’s research areas. Its listed publications include articles from the International Journal of Basic and Clinical Pharmacology and other medical journals. Institutional affiliation and bibliometric figures in the infobox are details and should be checked against current authoritative profiles. [2]
Research Contributions
The available publication list covers comparative medication studies, prescribing patterns and pharmacovigilance assessments. Examples include research concerning topical acne treatments, oral haematinics, asthma rescue medication and metformin. These subjects support a cautious description of contributions to clinical pharmacotherapy; a direct connection to oncology requires additional evidence. [1]
Publications
Examples in the record include a 2019 study of pharmacoepidemiology and pharmacohaemovigilance of iron preparations, a comparative study of topical anti-acne therapies, and research comparing arformoterol with salbutamol nebulisation. The record also lists work on metformin pharmacovigilance. [1]
Research Impact
Citation counts and h-index values are indicators of scholarly visibility, but they vary by database, indexing coverage and update date. The figures should not be interpreted as proof of clinical benefit or oncology expertise. The linked Google Scholar profile provides a route for checking the displayed publication list and citation information. [2]
Award Suitability
Consideration for the Cancer Research Excellence Award should depend on documented eligibility criteria and evidence of relevant cancer research, such as oncology publications, verified contributions or translational findings. Eligibility should therefore be assessed by the event organisers using verified supporting documents. [3]
Conclusion
Moumita Hazra’s scholarly record documents research related to pharmacology, medication safety and clinical treatment evaluation. These areas are relevant to medical research, but the available source does not establish a specific cancer research achievement or confirmed award. Further verification of oncology-related work and award criteria is necessary before making a stronger recognition claim.
External Links
References
- Google Scholar. (n.d.). Moumita Hazra: Author profile and listed publications.
https://scholar.google.com/citations?user=ZHKN3KwAAAAJ&hl=en
- Elsevier. (n.d.). Scopus author details: Moumita Hazra, Scopus.
https://www.scopus.com/authid/detail.uri?authorId=56500363800
- Medical Lab Scientist Awards. (n.d.). Event website
https://medicallabscientist.com/
- Hazra, M. (2022). A systematic review on metformin rational pharmacotherapeutics. International Journal of Basic & Clinical Pharmacology, 11(4), 331–335
https://doi.org/10.18203/2319-2003.ijbcp20221600
- Hazra, M. (2022). An analytical quantification clinical research, and an observational descriptive qualitative pharmacological research analysis on pharmacovigilance assessments of metformin monotherapy and combination therapies: A mixed-method study
https://doi.org/10.5455/njppp.2022.12.03128202218052022